查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1945792

CBD膳食补充品市场－全球产业规模、份额、趋势、机会及预测（依产品类型、通路、地区及竞争格局划分，2021-2031年）

CBD Nutraceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球 CBD 膳食补充剂市场预计将从 2025 年的 50.9 亿美元增长到 2031 年的 102.8 亿美元，复合年增长率为 12.43%。

该行业涵盖多种健康产品，包括以工业大麻提取的大麻二酚 (CBD) 配製的机能性食品、饮料和膳食补充剂。这些产品旨在提供诸如缓解压力和改善睡眠等治疗功效，且不具有任何精神活性作用。这一增长主要得益于消费者对预防医学态度的根本性转变，以及对天然植物性替代传统药物需求的日益增长。根据美国大麻圆桌会议的数据，作为全球市场的重要支柱，美国大麻产业预计在2024年将创造约284亿美元的收入。

市场概览
预测期 2027-2031
市场规模：2025年 50.9亿美元
市场规模：2031年 102.8亿美元
复合年增长率：2026-2031年 12.43%
成长最快的细分市场 网路药房
最大的市场 北美洲

然而，市场扩张的一大障碍是各国监管法规的零碎化。各国在CBD含量标准、标示要求以及CBD作为药品或食品的分类等方面的法律法规存在差异，导致合规环境复杂。这些不一致之处不仅使国际贸易困难重重，也限制了製造商获得关键金融服务，包括银行和支付处理服务。

市场驱动因素

消费者对CBD（大麻二酚）保健功效的认知不断提高，正从根本上改变着全球CBD膳食补充剂市场，使其从一种特殊产品跃升为一种标准的健康必需品。随着大众对大麻非精神活性特性的了解不断加深，越来越多的人群开始积极寻求植物来源解决方案来缓解慢性疼痛、焦虑和改善睡眠。这种态度的转变体现在其高使用率：根据2024年4月《福布斯健康》杂誌发表的题为“2024年CBD统计数据、资讯和使用情况”的报导，60%的美国成年人使用过或尝试过CBD产品。这种广泛的普及促使製造商突破传统酊剂的限制，为这个精明的消费群体开发专门的膳食补充剂。

电子商务和主流零售通路的扩张是推动成长的第二个主要动力，有效消除了获取障碍。 CBD产品从专卖店过渡到大型零售商的过渡显着提升了消费者的信任度和品牌知名度。 Charlotte's Web Holdings, Inc. 就是一个鲜明的例子。该公司在2024年11月发布的2024年第三季财报中宣布与沃尔玛达成零售扩张合作，将CBD外用产品引进827家门市。此外，CV Sciences, Inc. 在2024年11月发布的2024年第三季财报中实现了46.0%的毛利率，显示其业务营运日益稳定，也显示即使监管环境复杂，CBD市场仍能维持盈利。

市场挑战

监管分散化是目前全球CBD膳食补充剂市场成长的最大障碍。由于缺乏统一的法律体制，製造商被迫在错综复杂的相互衝突的法规网络中运营，不同司法管辖区对产品分类和允许的THC含量差异显着。这种不一致扰乱了全球供应链，并推高了遵循成本，因为企业必须频繁地重新配製产品并调整包装以满足不同的地区要求。此外，主要经济体中这些产品的法律地位存在不确定性，造成了高风险环境，阻碍了机构投资，限制了企业获得关键银行服务的管道，从而抑制了创新和资本流动。

这种监管不确定性的影响深远，对现有产业相关人员构成生存威胁。正如美国大麻圆桌会议在2024年报告所述，由于缺乏明确的联邦定义，提案的限制性法律改革有可能实际上禁止市场上约95%的大麻萃取物产品。这种巨大的不确定性阻碍了企业实施长期成长计划，并限制了该行业从利基市场发展成为全球健康经济中完全融合的组成部分的能力。

市场趋势

将CBG和CBN等微量大麻素添加到产品配方中，正在重塑产业内的差异化策略。我们正从泛泛的健康声明转向满足特定的生理需求。製造商正在分离这些微量大麻素，开发专门用于改善注意力和睡眠的辅助产品，利用与CBD协同作用的「协同效应」来增强治疗效果。这种向更先进成分的转变在近期针对失眠等慢性问题的创新中显而易见。例如，在2024年3月题为「Charlotte's Web推出助眠CBN软糖」的新闻稿中，Charlotte's Web Holdings宣布推出一款针对特定症状的配方，其中包含精确剂量的20毫克CBN，经临床设计，旨在帮助睡眠障碍患者。

消费者偏好的转变也促使他们更青睐可食用软糖产品而非传统的舌下酊剂，更重视口感与便利性。这一趋势正推动各公司调整产品线，以满足消费者对糖果甜点式服用方式的需求，这种服用方式能够无缝融入日常生活，同时避免胶囊和油剂带来的医疗联想。消费者对可食用产品的偏好也为专注于此类创新的品牌带来了强劲的财务表现。根据Flora Growth于2024年8月发布的2024年第二季财务报告，其子公司Just CBD的销售额达440万美元，毛利率高达34%，这一业绩显然得益于其软糖产品线的高销量。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球CBD膳食补充品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（CBD酊剂、胶囊/软胶囊、CBD软糖、其他）
    • 按分销管道（医院药房、零售药房、网路药房）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美CBD膳食补充剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲CBD膳食补充剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区CBD膳食补充剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲CBD膳食补充剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲CBD膳食补充剂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球CBD膳食补充品市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Gaia Botanicals LLC
  • CV Sciences, Inc.
  • Elixinol LLC
  • Garden of Life
  • Isodiol International Inc
  • Medical Marijuana Inc
  • Medterra

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19545

The Global CBD Nutraceuticals Market is projected to expand from USD 5.09 Billion in 2025 to USD 10.28 Billion by 2031, reflecting a CAGR of 12.43%. This sector encompasses a variety of wellness products, such as functional foods, beverages, and dietary supplements infused with industrial hemp-derived cannabidiol, which are designed to offer therapeutic advantages like stress reduction and better sleep without psychoactive effects. This growth is largely fueled by a fundamental consumer shift towards preventative health measures and a rising demand for natural, plant-based substitutes for conventional medicines. Data from the U.S. Hemp Roundtable indicates that the U.S. hemp industry, a key pillar of the global market, generated roughly $28.4 billion in revenue during 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.09 Billion
Market Size 2031USD 10.28 Billion
CAGR 2026-203112.43%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Nevertheless, a major obstacle hindering widespread market growth is the ongoing regulatory fragmentation across different nations. Conflicting legal frameworks concerning allowed CBD levels, labeling mandates, and categorization as either medicine or food establish a difficult compliance environment. This inconsistency complicates international commerce and limits manufacturers' access to vital financial services, including banking and payment processing.

Market Driver

Increasing consumer knowledge regarding therapeutic health advantages is fundamentally transforming the Global CBD Nutraceuticals Market, elevating cannabidiol from a specialized product to a standard wellness essential. As the public gains a better understanding of hemp's non-psychoactive attributes, a larger demographic is actively pursuing plant-based solutions for chronic pain, anxiety, and sleep management. This change in attitude is reflected in high usage rates; according to an April 2024 Forbes Health article titled 'CBD Statistics, Data And Use In 2024', 60% of adults in the U.S. have used or tried a CBD product. Such widespread adoption is prompting manufacturers to innovate past basic tinctures, creating specialized nutraceuticals for an increasingly informed customer base.

The broadening of e-commerce and mainstream retail distribution channels acts as the second major catalyst for growth, effectively removing accessibility hurdles. Moving CBD products from exclusive dispensaries to major retailers has notably improved consumer confidence and brand exposure. A significant illustration of this shift occurred when Charlotte's Web Holdings Inc., in its 'Reports 2024 Third Quarter Financial Results' from November 2024, announced an expanded retail footprint through a partnership with Walmart, placing CBD topicals in 827 additional locations. Additionally, demonstrating improved operational stability, CV Sciences, Inc. reported a gross margin of 46.0% in its 'Reports Third Quarter 2024 Financial Results' in November 2024, indicating a maturing market able to maintain profitability despite regulatory complexities.

Market Challenge

Regulatory fragmentation constitutes the most significant obstacle currently holding back the Global CBD Nutraceuticals Market's growth. The lack of a cohesive legal structure compels manufacturers to operate within a complicated mix of conflicting regulations, where product classifications and allowable THC levels vary widely across jurisdictions. These inconsistencies interrupt global supply chains and drive up compliance expenses, as businesses are forced to frequently reformulate products and adjust packaging to satisfy differing regional requirements. Moreover, the uncertain legal standing of these items in key economies fosters a high-risk atmosphere that deters institutional investment and limits access to critical banking services, hindering innovation and capital movement.

The consequences of this regulatory volatility are profound, posing existential threats to established industry participants. As reported by the U.S. Hemp Roundtable in 2024, restrictive legislative changes proposed due to the absence of precise federal definitions risked effectively banning roughly 95% of all hemp extract products available on the market. Such intense uncertainty stops companies from implementing long-term growth plans and restricts the sector's capacity to evolve from a niche market into a fully integrated element of the global wellness economy.

Market Trends

The rise of minor cannabinoids such as CBG and CBN in product formulations is actively reshaping differentiation strategies within the industry, moving beyond general wellness assertions to address specific physiological needs. Manufacturers are increasingly isolating these minor cannabinoids to create distinct aids for focus and sleep, leveraging the "entourage effect" where these compounds function synergistically with CBD to improve therapeutic results. This move towards sophisticated ingredients is highlighted by recent innovations aimed at chronic issues like insomnia; for instance, Charlotte's Web Holdings, Inc. announced in a March 2024 press release titled 'Charlotte's Web Launches Stay Asleep CBN Gummies' the launch of a condition-specific formula providing a precise 20 mg dose of CBN, clinically designed to assist consumers with sleep disruptions.

A parallel shift in consumer preference is seen in the growing dominance of edible and gummy formats, which prioritize taste and convenience over conventional sublingual tinctures. This trend is driving companies to reorganize their product offerings, as customers prefer familiar, confectionery-style delivery methods that fit easily into daily life without the medicinal stigma linked to capsules or oils. This preference for edibles is resulting in strong financial outcomes for brands focusing on such innovations; according to Flora Growth Corp.'s 'Reports Second Quarter 2024 Financial Results' from August 2024, its JustCBD subsidiary sustained a robust gross profit margin of 34% on sales of $4.4 million, a performance explicitly attributed to the high sales volume of its gummy product lines.

Key Market Players

  • Gaia Botanicals LLC
  • CV Sciences, Inc.
  • Elixinol LLC
  • Garden of Life
  • Isodiol International Inc
  • Medical Marijuana Inc
  • Medterra

Report Scope

In this report, the Global CBD Nutraceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

CBD Nutraceuticals Market, By Product Type

  • CBD Tinctures
  • Capsules & Softgels
  • CBD Gummies
  • Others

CBD Nutraceuticals Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

CBD Nutraceuticals Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CBD Nutraceuticals Market.

Available Customizations:

Global CBD Nutraceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global CBD Nutraceuticals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others)
    • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America CBD Nutraceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States CBD Nutraceuticals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada CBD Nutraceuticals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico CBD Nutraceuticals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe CBD Nutraceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany CBD Nutraceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. France CBD Nutraceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom CBD Nutraceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy CBD Nutraceuticals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain CBD Nutraceuticals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia Pacific CBD Nutraceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China CBD Nutraceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India CBD Nutraceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan CBD Nutraceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea CBD Nutraceuticals Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia CBD Nutraceuticals Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Distribution Channel

9. Middle East & Africa CBD Nutraceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia CBD Nutraceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. UAE CBD Nutraceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. South Africa CBD Nutraceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Distribution Channel

10. South America CBD Nutraceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil CBD Nutraceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Colombia CBD Nutraceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. Argentina CBD Nutraceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global CBD Nutraceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Gaia Botanicals LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CV Sciences, Inc.
  • 15.3. Elixinol LLC
  • 15.4. Garden of Life
  • 15.5. Isodiol International Inc
  • 15.6. Medical Marijuana Inc
  • 15.7. Medterra

16. Strategic Recommendations

17. About Us & Disclaimer